Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer

Published:2009-11-11 Issue:3 Volume:65 Page:597-605
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Pourgholami Mohammad H.,Szwajcer Michael,Chin Melvin,Liauw Winston,Seef Jonathan,Galettis Peter,Morris David L.,Links Matthew

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-009-1157-8.pdf

Reference24 articles.

1. Dayan AD (2003) Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop 86:141–159

2. Marriner SE, Morris DL, Dickson B et al (1986) Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol 30:705–708

3. Sotelo J, Jung H (1998) Pharmacokinetic optimisation of the treatment of neurocysticercosis. Clin Pharmacokinet 34:503–515

4. Horton J (2002) Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations. Curr Opin Infect Dis 15:599–608

5. Lacey E, Brady RL, Prichard RK et al (1987) Comparison of inhibition of polymerisation of mammalian tubulin and helminth ovicidal activity by benzimidazole carbamates. Vet Parasitol 23:105–119

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic, Alveolar and Neotropical Echinococcosis;Manson's Tropical Diseases;2024

2. Study of Drug Delivery Using Purely Organic Macrocyclic Containers─Cucurbit[7]uril and Pillararene;ACS Omega;2023-12-04

3. Benzimidazoles Containing Piperazine Skeleton at C-2 Position as Promising Tubulin Modulators with Anthelmintic and Antineoplastic Activity;Pharmaceuticals;2023-10-25

4. Albumin nanostructure assisted ABZ anti-parasite immune therapy for T. spiralis muscle infection;Biomaterials Advances;2023-07

5. Melatonin in Combination with Albendazole or Albendazole Sulfoxide Produces a Synergistic Cytotoxicity against Malignant Glioma Cells through Autophagy and Apoptosis;Brain Sciences;2023-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3